How Will PYC’s A$653m Raise Propel Its RNA Therapy Pipeline to 2030?

middle.news 9:50am on Monday 2nd of February, 2026 AEDT • Healthcare Read Story

How Will PYC’s A$653m Raise Propel Its RNA Therapy Pipeline to 2030?

9:50am on Monday 2nd of February, 2026 AEDT Key Points A$653 million capital raise via institutional placement and 3-for-5 entitlement offer Funds to advance four RNA therapeutic candidates targeting genetic diseases Cash runway extended to calendar year 2030 Underwritten up to A$200 million by seven existing sophisticated investors Read Story

middle. Tap to Read Tap the card to read the full analysis about Pyc Therapeutics (ASX:PYC) OPEN ARTICLE